PARALLAX HEALTH SCIENCES, INC. (CIK: 0001388410) EDGAR, Information, Filings... CompaniesBIO.Com

PARALLAX HEALTH SCIENCES, INC.

Mailing address
3415 S SEPULVEDA BLVD, SUITE 1100-6592, LOS ANGELES, Nevada, 90034
Phone
888-263-9799
State location
California
State of incorporation
Nevada
Fiscal year end
December 31
SIC
8000 - (CF Office: Office of Life Sciences) SERVICES-HEALTH SERVICES
Filings
N/A

PARALLAX HEALTH SCIENCES, INC. (CIK: 0001388410) is an American company incorporated in the state of California. Head office is located at 3415 S SEPULVEDA BLVD, SUITE 1100-6592, LOS ANGELES, California, 90034. Work in the industry 8000 - (CF Office: Office of Life Sciences) SERVICES-HEALTH SERVICES. PARALLAX HEALTH SCIENCES, INC. is a public company and trade via Over-The-Counter (OTC).

Old names:

Endeavor Power Corp from 2008-16-Oct to 2014-07-Jan
Endeavor Uranium, Inc. from 2007-13-Nov to 2008-31-Dec
VB Trade Inc from 2007-05-Mar to 2007-24-Oct

Owner	Filings	Transaction Date	Type of Owner
APPELL DAVID	0001778977	May-15-2019	officer: Chief Operating Officer
BRADLEY NATHANIEL T	0001755804	Jun-04-2018	director, other: Chief Technology Officer
OGDEN JOHN L	0001428638	Apr-05-2018	director
ARENA PAUL R	0001275657	Jul-01-2017	director, officer: President, CEO
WITHROW EDWARD W. JR	0001471358	Oct-05-2015	director
BUCCI CALLI	0001621244	Jul-31-2014	director, officer: CFO
WITHROW EDWARD W III	0001305862	Dec-31-2012	director, 10 percent owner
Gorlach Jorn	0001596048	Dec-31-2012	director, 10 percent owner
REDMOND JOSEPH MICHAEL	0001596559	Dec-31-2012	director, officer: President, CEO
WEED RICHARD O	0001209791	May-07-2010	director, officer: CEO, CFO, Secretary
Wilder Brent	0001480833	Dec-26-2009	director, officer: CEO/CFO/Secretary/Treasurer
MITCHELL MARVIN A	0001413259	Aug-20-2007	director, officer: Head Geologist/VP Exploration
Friedman Avi	0001390444	Mar-14-2007	director, 10 percent owner, officer: President/Treasurer
Primack Ray	0001390446	Mar-14-2007	director, 10 percent owner, officer: Secretary

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by PARALLAX HEALTH SCIENCES, INC.

Filings	Format	Description	Filed/Effective	File/Film Number
REVOKED	Document	Acc-no: 9999999997-22-003995 (34 Act) Size: 481 KB	Aug-22-2022	000-52534 221185379
8-K	Document	Current report filing Acc-no: 0001388410-22-000009 (34 Act) Size: 930 KB	May-12-2022	000-52534 22915220
5/A	Document	Amendment to Annual statement of changes in beneficial ownership of securities Acc-no: 0001388410-22-000007 ( Act) Size: 5 KB	Mar-29-2022
8-K	Document	Current report filing Acc-no: 0001388410-22-000006 (34 Act) Size: 33 KB	Mar-28-2022	000-52534 22775073
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001388410-22-000004 ( Act) Size: 6 KB	Mar-17-2022
5	Document	Annual statement of changes in beneficial ownership of securities Acc-no: 0001388410-22-000003 ( Act) Size: 12 KB	Mar-17-2022
5/A	Document	Amendment to Annual statement of changes in beneficial ownership of securities Acc-no: 0001388410-22-000002 ( Act) Size: 10 KB	Mar-17-2022
8-K	Document	Current report filing Acc-no: 0001388410-21-000022 (34 Act) Size: 94 KB	Sep-29-2021	000-52534 211289027
8-K	Document	Current report filing Acc-no: 0001388410-21-000018 (34 Act) Size: 31 KB	Aug-31-2021	000-52534 211225222
8-K	Document	Current report filing Acc-no: 0001388410-21-000016 (34 Act) Size: 28 KB	Aug-23-2021	000-52534 211195166
8-K/A	Document	Amendment to Current report filing Acc-no: 0001388410-21-000013 (34 Act) Size: 35 KB	Jul-13-2021	000-52534 211088022
8-K	Document	Current report filing Acc-no: 0001388410-21-000011 (34 Act) Size: 34 KB	Jul-13-2021	000-52534 211086608
8-K	Document	Current report filing Acc-no: 0001388410-21-000007 (34 Act) Size: 27 KB	Apr-08-2021	000-52534 21813570
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001388410-20-000063 (34 Act) Size: 101 KB	Jun-29-2020	000-52534 20997703
10-K/A	Document	Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0001388410-20-000053 (34 Act) Size: 7891 KB	May-20-2020	000-52534 20896953
8-K	Document	Current report filing Acc-no: 0001388410-20-000047 (34 Act) Size: 70 KB	May-18-2020	000-52534 20888022
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001388410-20-000045 (34 Act) Size: 2722 KB	May-18-2020	000-52534 20887610
8-K	Document	Current report filing Acc-no: 0001388410-20-000039 (34 Act) Size: 35 KB	May-15-2020	000-52534 20879487
8-K	Document	Current report filing Acc-no: 0001388410-20-000037 (34 Act) Size: 29 KB	Apr-15-2020	000-52534 20792119
8-K	Document	Current report filing Acc-no: 0001388410-20-000035 (34 Act) Size: 93 KB	Apr-09-2020	000-52534 20783978

Recent 20 filings. View all PARALLAX HEALTH SCIENCES, INC. filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

PARALLAX HEALTH SCIENCES, INC. overview
PARALLAX HEALTH SCIENCES, INC. job
PARALLAX HEALTH SCIENCES, INC. stock
PARALLAX HEALTH SCIENCES, INC. ownership
PARALLAX HEALTH SCIENCES, INC. CEO
PARALLAX HEALTH SCIENCES, INC. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.